TRacking Atopic Dermatitis Infants and Their Microbiome (TRAM)
NCT06578351 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60
Last updated 2026-02-04
Summary
TRacking Atopic dermatitis Infants and their Microbiome: A study to primarily assess the user experience of parents of infants with early onset eczema and parents of healthy infants on OneBiome real-world evidence research platform.
Conditions
- Atopic Dermatitis
- Pediatric ALL
Sponsors & Collaborators
-
Danone Asia Pacific Holdings Pte, Ltd.
lead INDUSTRY
Principal Investigators
-
Bee Wah Lee, MBBS · The Child and Allergy Clinic - Mount Elizabeth Hospital
-
Wen Chin Chiang, MBBS · Chiang's Children Allergy and Asthma Clinic - Mount Elizabeth Hospital
Eligibility
- Min Age
- 0 Months
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-04-08
- Primary Completion
- 2026-01-26
- Completion
- 2026-01-26
Countries
- Singapore
Study Locations
More Related Trials
-
A 32-week Trial to Evaluate the Efficacy and Safety of Tralokinumab in Subjects With Moderate-to-severe Atopic Hand Eczema Who Are Candidates for Systemic Therapy
NCT05958407 ·Status: COMPLETED ·Phase: PHASE3
-
Longitudinal Endotyping Of Atopic Dermatitis Through Transcriptomic Skin Analysis
NCT05436535 ·Status: COMPLETED ·Phase: PHASE4
-
Tralokinumab Monotherapy for Children With Moderate-to-severe Atopic Dermatitis - TRAPEDS 1 (TRAlokinumab PEDiatric Trial no. 1)
NCT05388760 ·Status: COMPLETED ·Phase: PHASE2
-
Preventive Treatment of Tacrolimus Ointment in Children With Atopic Dermatitis
NCT01745159 ·Status: COMPLETED ·Phase: PHASE4
-
Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
NCT03562377 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Crisaborole Ointment 2% in Children Aged 3-24 Months With Mild to Moderate Atopic Dermatitis
NCT03356977 ·Status: COMPLETED ·Phase: PHASE4
-
Observational Evaluation of Atopic Dermatitis in Pediatric Patients
NCT03687359 ·Status: ACTIVE_NOT_RECRUITING
-
Phase 2 Study to Evaluate the Efficacy and Safety of Tralokinumab in Adults With Atopic Dermatitis
NCT02347176 ·Status: COMPLETED ·Phase: PHASE2
-
An Efficacy and Safety Study of Tacrolimus Ointment in Pediatric Participants With Atopic Dermatitis
NCT01782729 ·Status: COMPLETED ·Phase: PHASE4
-
Monitoring Pregnancy and Infant Outcomes Following Tralokinumab Exposure During Pregnancy in the US and Canada - PROTECT
NCT05938478 ·Status: RECRUITING
-
Tralokinumab Monotherapy for Adolescent Subjects With Moderate to Severe Atopic Dermatitis - ECZTRA 6 (ECZema TRAlokinumab Trial no. 6).
NCT03526861 ·Status: COMPLETED ·Phase: PHASE3
-
Tralokinumab in Combination With Topical Corticosteroids in Japanese Subjects With Moderate-to-severe Atopic Dermatitis
NCT04587453 ·Status: COMPLETED ·Phase: PHASE3
-
Moisturizer Mediated Prevention of Symptoms of Atopic Dermatitis in Early Childhood
NCT04398758 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy and Safety of Pimecrolimus Cream 1% in Patients ≥ 3 Months of Age With Mild or Moderate Atopic Dermatitis
NCT00150059 ·Status: COMPLETED ·Phase: PHASE4
-
Targeted Microbiome Transplant in Atopic Dermatitis
NCT03151148 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Tacrolimus Ointment Pharmacokinetics in Infants With Atopic Dermatitis
NCT00535691 ·Status: COMPLETED ·Phase: PHASE2
-
Systemic Therapies for Pediatric Atopic Dermatitis
NCT01447381 ·Status: UNKNOWN
-
Pharmacokinetic Study of Topical GSK2894512 Cream
NCT02466152 ·Status: COMPLETED ·Phase: PHASE1
-
An Efficacy and Safety Study of Tacrolimus Ointment in Adult Participants With Atopic Dermatitis
NCT01828879 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Tralokinumab Treatment of Atopic Dermatitis on Skin Barrier Function
NCT04556461 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of the Kinetic Properties of an Autologous Microbiome Transplant in Adult Atopic Dermatitis Patients
NCT02144142 ·Status: WITHDRAWN ·Phase: PHASE2
-
Pharmacokinetics, Safety and Efficacy of Nemolizumab in Participants With Moderate-to-Severe Atopic Dermatitis
NCT04921345 ·Status: COMPLETED ·Phase: PHASE2
-
TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis
NCT03745651 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluating the Efficacy and Tolerability of Ceradan Advanced Cream in the Treatment of Children With Atopic Dermatitis
NCT05136261 ·Status: UNKNOWN ·Phase: PHASE3
-
A Long-term Study of the Medicine Called Abrocitinib in Children Aged 2 Years and Older With Moderate to Severe Eczema
NCT06807281 ·Status: RECRUITING ·Phase: PHASE3